“Capmatinib in patients with MET-positive advanced non-small cell lung cancer: analysis of the Russian cohort in the Geometry mono-1 study”, Вопр. онкол., vol. 68, no. 6, pp. 758–767, Dec. 2022, doi: 10.37469/0507-3758-2022-68-6-758-767.